» Articles » PMID: 34073356

Anticancer Effects of Lingonberry and Bilberry on Digestive Tract Cancers

Overview
Date 2021 Jun 2
PMID 34073356
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Wild berries are part of traditional Nordic diets and are a rich source of phytochemicals, such as polyphenols. Various berry treatments have shown to interfere with cancer progression in vitro and in vivo. Here, we systematically reviewed the anticancer effects of two Nordic wild berries of the genus, lingonberry () and bilberry (), on digestive tract cancers. The review was conducted according to the PRISMA 2020 guidelines. Searches included four databases: PubMed, Scopus, Web of Science, and CAB abstracts. Publications not written in English, case-reports, reviews, and conference abstracts were excluded. Moreover, studies with only indirect markers of cancer risk or studies with single compounds not derived from lingonberry or bilberry were not included. Meta-analysis was not performed. The majority (21/26) of studies investigated bilberry and colorectal cancer. Experimental studies on colorectal cancer indicated that bilberry inhibited intestinal tumor formation and cancer cell growth. One uncontrolled pilot human study supported the inhibitory potential of bilberry on colorectal cancer cell proliferation. Data from all 10 lingonberry studies suggests potent inhibition of cancer cell growth and tumor formation. In conclusion, in vitro and animal models support the antiproliferative and antitumor effects of various bilberry and lingonberry preparations on digestive tract cancers.

Citing Articles

Exploring the potential protective role of anthocyanins in mitigating micro/nanoplastic-induced reproductive toxicity: A steroid receptor perspective.

Zhang J, Liu W, Cui F, Kolehmainen M, Chen J, Zhang L J Pharm Anal. 2025; 15(2):101148.

PMID: 39925697 PMC: 11803829. DOI: 10.1016/j.jpha.2024.101148.


Increasing the Content of Bioactive Compounds in Apple Juice Through Direct Ultrasound-Assisted Extraction from Bilberry Pomace.

Nour V Foods. 2025; 13(24.

PMID: 39767086 PMC: 11675781. DOI: 10.3390/foods13244144.


and Insights into a Broccoli Byproduct as a Healthy Ingredient for the Management of Alzheimer's Disease and Aging through Redox Biology.

Navarro-Hortal M, Romero-Marquez J, Lopez-Bascon M, Sanchez-Gonzalez C, Xiao J, Sumalla-Cano S J Agric Food Chem. 2024; 72(10):5197-5211.

PMID: 38477041 PMC: 10941188. DOI: 10.1021/acs.jafc.3c05609.


Experimental Studies on the Therapeutic Potential of Berries in Breast Cancer-A Review.

Alsharairi N Plants (Basel). 2024; 13(2).

PMID: 38256707 PMC: 10818444. DOI: 10.3390/plants13020153.


Src Tyrosine Kinase Inhibitory and Antioxidant Activity of Black Chokeberry and Bilberry Fruit Extracts Rich in Chlorogenic Acid.

Vladimir-Knezevic S, Stefan M, Blazekovic B, Jelic D, Petkovic T, Mandic M Int J Mol Sci. 2023; 24(21).

PMID: 37958496 PMC: 10650546. DOI: 10.3390/ijms242115512.


References
1.
Olsson M, Gustavsson K, Andersson S, Nilsson A, Duan R . Inhibition of cancer cell proliferation in vitro by fruit and berry extracts and correlations with antioxidant levels. J Agric Food Chem. 2004; 52(24):7264-71. DOI: 10.1021/jf030479p. View

2.
Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

3.
Sogo T, Kumamoto T, Ishida H, Hisanaga A, Sakao K, Terahara N . Comparison of the inhibitory effects of delphinidin and its glycosides on cell transformation. Planta Med. 2014; 81(1):26-31. DOI: 10.1055/s-0034-1383311. View

4.
Munagala R, Aqil F, Jeyabalan J, Agrawal A, Mudd A, Kyakulaga A . Exosomal formulation of anthocyanidins against multiple cancer types. Cancer Lett. 2017; 393:94-102. PMC: 5837866. DOI: 10.1016/j.canlet.2017.02.004. View

5.
Cirmi S, Navarra M, Woodside J, Cantwell M . Citrus fruits intake and oral cancer risk: A systematic review and meta-analysis. Pharmacol Res. 2018; 133:187-194. DOI: 10.1016/j.phrs.2018.05.008. View